Latest News
Conference Coverage
Investigational gene therapy for medically refractory Parkinson’s shows promise
ATLANTA – A randomized, double-blind, placebo surgery–controlled trial of VY-AADC01 is currently recruiting subjects.
Conference Coverage
Many oromandibular dystonia patients report improvement after botulinum toxin injections
ATLANTA – Cohort of patients is the largest yet described.
Conference Coverage
BAN2401 subanalyses attempt to ease concerns over study design and findings
Conference Coverage
Higher BMI associated with greater loss of gray matter volume in MS
ATLANTA – Cohort may not be representative of the general MS population.
Conference Coverage
Statins cut all-cause mortality in spinal cord injury
ATLANTA – Analysis marks the first clinical study of its kind.
News from the FDA/CDC
FDA approves Xyrem to treat children with narcolepsy
The central nervous system depressant was approved for the treatment of cataplexy and excessive daytime sleepiness.
Feature
Trump scheme for Part B drugs raises red flags
Doctors raise concerns that past mistakes will recur or access issues will increase.
Conference Coverage
Acute kidney injury linked to later dementia
SAN DIEGO – Vascular disease, especially of the small blood vessels, may be a culprit.
From the Journals
Antipsychotic drugs failed to shorten ICU delirium
The mechanisms of brain dysfunction targeted by antipsychotics may not play a major role in delirium.
Feature
Experts: Kavanaugh may have lasting impact on health care
With the addition of Brett Kavanaugh to the U.S. Supreme Court, legal analysts say state abortion rights may diminish and pieces of the federal...
Conference Coverage
IDEAS study meets first aim of changing 3-month clinical management, health outcomes
BARCELONA – The scan benefited both amyloid-positive and -negative patients.